Clinical trials
Completed Phase 2 Malaria, Falciparum trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 4 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 5 |
| Medicines for Malaria Venture | 5 |
| Novartis Pharmaceuticals | 4 |
| Sanaria Inc. | 4 |
| London School of Hygiene and Tropical Medicine | 3 |
| U.S. Army Medical Research and Development Command | 3 |
| Medical University of Vienna | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| University of Oxford | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Falciparum | 42 |
| Malaria | 21 |
| Malaria, Vivax | 4 |
| Parasitic Diseases | 3 |
| Coccidiosis | 2 |
| Asymptomatic Infections | 1 |
| Elimination Disorders | 1 |
| Infections | 1 |
| Protozoan Infections | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.